INVESTINGMerck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 BillionBy Martin BaccardaxDec 9, 2019 9:47 AM EST
INVESTINGArQule Jumps on Positive Phase 1 Blood Cancer Trial ResultsBy Tony OwusuJun 14, 2019 10:31 AM EDT
MARKETSInsider Trading Alert - SUMR, CVO And ARQL Traded By InsidersBy TheStreet WireDec 21, 2015 12:16 PM EST
MARKETSInsider Trading Alert - ARQL, MTSC And PFNX Traded By InsidersBy TheStreet WireDec 18, 2015 10:45 AM EST
MARKETSInsider Trading Alert - SAVE, ARQL And THST Traded By InsidersBy TheStreet WireDec 17, 2015 2:00 PM EST
MARKETSInsider Trading Alert - ORM, OLBK And ARQL Traded By InsidersBy TheStreet WireDec 15, 2015 12:30 PM EST
MARKETSInsider Trading Alert - TIPT, RDNT And ARQL Traded By InsidersBy TheStreet WireDec 14, 2015 10:45 AM EST
MARKETSInsider Trading Alert - ITG, CDXS And ARQL Traded By InsidersBy James Giaquinto Nov 21, 2014 2:45 PM EST
INVESTING4 Biotech Stocks Under $10 to Watch for Breakout TradesBy Roberto PedoneJun 20, 2014 8:27 AM EDT
STOCKSArqule Shutters Lung Cancer Study Early Due to FutilityBy Adam FeuersteinOct 2, 2012 7:55 AM EDT
STOCKSArqule Shares Slide on Lung Cancer Drug Safety ConcernBy Adam FeuersteinAug 29, 2012 10:15 AM EDT
STOCKSASCO '12 Abstract Dump: Cancer Stocks in Focus (Update)By Adam FeuersteinMay 17, 2012 6:19 AM EDT
